JP2022526266A5 - - Google Patents
Info
- Publication number
- JP2022526266A5 JP2022526266A5 JP2021555445A JP2021555445A JP2022526266A5 JP 2022526266 A5 JP2022526266 A5 JP 2022526266A5 JP 2021555445 A JP2021555445 A JP 2021555445A JP 2021555445 A JP2021555445 A JP 2021555445A JP 2022526266 A5 JP2022526266 A5 JP 2022526266A5
- Authority
- JP
- Japan
- Prior art keywords
- section
- compound
- cancer
- compound according
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024064400A JP7789832B2 (ja) | 2019-03-15 | 2024-04-12 | がんを治療するための組成物及び方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819322P | 2019-03-15 | 2019-03-15 | |
| US62/819,322 | 2019-03-15 | ||
| US201962904241P | 2019-09-23 | 2019-09-23 | |
| US62/904,241 | 2019-09-23 | ||
| PCT/US2020/022743 WO2020190765A2 (en) | 2019-03-15 | 2020-03-13 | Compositions and methods for treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064400A Division JP7789832B2 (ja) | 2019-03-15 | 2024-04-12 | がんを治療するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526266A JP2022526266A (ja) | 2022-05-24 |
| JP2022526266A5 true JP2022526266A5 (https=) | 2023-03-20 |
| JP7474269B2 JP7474269B2 (ja) | 2024-04-24 |
Family
ID=72521289
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555445A Active JP7474269B2 (ja) | 2019-03-15 | 2020-03-13 | がんを治療するための組成物及び方法 |
| JP2024064400A Active JP7789832B2 (ja) | 2019-03-15 | 2024-04-12 | がんを治療するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064400A Active JP7789832B2 (ja) | 2019-03-15 | 2024-04-12 | がんを治療するための組成物及び方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US11377451B2 (https=) |
| EP (1) | EP3938354A4 (https=) |
| JP (2) | JP7474269B2 (https=) |
| KR (1) | KR102809395B1 (https=) |
| CN (2) | CN115215808B (https=) |
| AU (1) | AU2020241703B2 (https=) |
| BR (1) | BR112021018295A2 (https=) |
| CA (1) | CA3133688A1 (https=) |
| CL (1) | CL2021002409A1 (https=) |
| CO (1) | CO2021013496A2 (https=) |
| CR (1) | CR20210498A (https=) |
| IL (1) | IL286350A (https=) |
| MX (1) | MX2021011272A (https=) |
| PH (1) | PH12021552208A1 (https=) |
| SA (1) | SA521430328B1 (https=) |
| SG (1) | SG11202109662YA (https=) |
| WO (1) | WO2020190765A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111868039A (zh) * | 2017-09-26 | 2020-10-30 | 加利福尼亚大学董事会 | 用于治疗癌症的组合物和方法 |
| KR102809395B1 (ko) | 2019-03-15 | 2025-05-16 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 암을 치료하기 위한 조성물 및 방법 |
| US20240058340A1 (en) * | 2020-09-21 | 2024-02-22 | The Regents Of The University Of California | Compositions and methods for treating cancer |
| WO2022061299A1 (en) * | 2020-09-21 | 2022-03-24 | The Regents Of The University Of California | Non-invasive functional companion assays for oncogene targeted therapy for brain cancer |
| WO2022061201A1 (en) * | 2020-09-21 | 2022-03-24 | The Regents Of The University Of California | Compositions and methods for treating cancer |
| WO2022155311A1 (en) * | 2021-01-14 | 2022-07-21 | The Regents Of The University Of California | Methods and systems for analysis of drug target engagement and treatment of cancer |
| TW202309022A (zh) | 2021-04-13 | 2023-03-01 | 美商努法倫特公司 | 用於治療具egfr突變之癌症之胺基取代雜環 |
| US20240165132A1 (en) * | 2021-05-12 | 2024-05-23 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| CN113307799B (zh) * | 2021-05-21 | 2022-07-19 | 大连医科大学 | 一种检测葡萄糖醛酸转移酶1a1荧光探针及其应用 |
| EP4405360A4 (en) * | 2021-09-23 | 2025-08-20 | Erasca Inc | POLYMORPHIC FORMS OF EGFR INHIBITOR |
| WO2023244639A1 (en) * | 2022-06-14 | 2023-12-21 | The Regents Of The University Of California | Methods of predicting cns cancer response to treatment with egfr inhibitors |
| WO2024081447A1 (en) * | 2022-10-14 | 2024-04-18 | The Regents Of The University Of California | Egfr inhibitors for treating lung cancer |
| WO2024102177A1 (en) * | 2022-11-08 | 2024-05-16 | The Regents Of The University Of California | Combination therapies for the treatment of brain cancer |
| WO2025117739A1 (en) * | 2023-11-27 | 2025-06-05 | Erasca, Inc. | Compositions and methods for treating cancer |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5538325A (en) * | 1978-09-11 | 1980-03-17 | Sankyo Co Ltd | 4-anilinoquinazoline derivative and its preparation |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| US6706721B1 (en) | 1998-04-29 | 2004-03-16 | Osi Pharmaceuticals, Inc. | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| KR100397792B1 (ko) * | 2001-06-28 | 2003-09-13 | 한국과학기술연구원 | 4-(페닐아미노)-[1,4]디옥사노[2,3-ｇ]퀴나졸린 유도체 및그의 제조방법 |
| CN1854130B (zh) | 2005-04-15 | 2011-04-20 | 中国医学科学院药物研究所 | 喹唑啉衍生物、及其制法和药物组合物与用途 |
| WO2008046242A1 (fr) | 2006-10-16 | 2008-04-24 | Institute Of Mataria Medica, Chinese Academy Of Medical Sciences | Nouveaux dérivés quinazolines, leurs procédés de préparation et leurs utilisations |
| WO2011035540A1 (zh) | 2009-09-28 | 2011-03-31 | 齐鲁制药有限公司 | 作为酪氨酸激酶抑制剂的4-（取代苯胺基）喹唑啉衍生物 |
| ITPD20110091A1 (it) | 2011-03-24 | 2012-09-25 | Univ Padova | Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico. |
| NZ732511A (en) * | 2014-12-15 | 2018-11-30 | Univ Michigan Regents | Small molecule inhibitors of egfr and pi3k |
| CA2974442A1 (en) * | 2015-02-03 | 2016-08-11 | Trillium Therapeutics Inc. | Novel fluorinated derivatives as egfr inhibitors useful for treating cancers |
| CN105017163A (zh) | 2015-08-25 | 2015-11-04 | 佛山市赛维斯医药科技有限公司 | 双乙氧基苯并喹唑啉类酪氨酸激酶抑制剂、制备方法及其用途 |
| US10473255B2 (en) | 2015-12-29 | 2019-11-12 | Ge-Hitachi Nuclear Energy Americas Llc | Reactor pressure vessel including pipe restraint device, and/or a pipe restraint device |
| AU2017204973A1 (en) | 2016-01-06 | 2018-07-12 | Trillium Therapeutics Inc. | Novel fluorinated quinazoline derivatives as EGFR inhibitors |
| CN106432202B (zh) | 2016-09-22 | 2019-04-02 | 郑州大学第一附属医院 | 喹唑啉类衍生物及其应用 |
| CN111868039A (zh) * | 2017-09-26 | 2020-10-30 | 加利福尼亚大学董事会 | 用于治疗癌症的组合物和方法 |
| KR102809395B1 (ko) | 2019-03-15 | 2025-05-16 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 암을 치료하기 위한 조성물 및 방법 |
| WO2022061201A1 (en) | 2020-09-21 | 2022-03-24 | The Regents Of The University Of California | Compositions and methods for treating cancer |
| US20240058340A1 (en) | 2020-09-21 | 2024-02-22 | The Regents Of The University Of California | Compositions and methods for treating cancer |
| WO2022061299A1 (en) | 2020-09-21 | 2022-03-24 | The Regents Of The University Of California | Non-invasive functional companion assays for oncogene targeted therapy for brain cancer |
| EP4405360A4 (en) * | 2021-09-23 | 2025-08-20 | Erasca Inc | POLYMORPHIC FORMS OF EGFR INHIBITOR |
| WO2023244639A1 (en) * | 2022-06-14 | 2023-12-21 | The Regents Of The University Of California | Methods of predicting cns cancer response to treatment with egfr inhibitors |
-
2020
- 2020-03-13 KR KR1020217032873A patent/KR102809395B1/ko active Active
- 2020-03-13 BR BR112021018295A patent/BR112021018295A2/pt unknown
- 2020-03-13 MX MX2021011272A patent/MX2021011272A/es unknown
- 2020-03-13 CN CN202210268803.XA patent/CN115215808B/zh active Active
- 2020-03-13 WO PCT/US2020/022743 patent/WO2020190765A2/en not_active Ceased
- 2020-03-13 EP EP20773177.9A patent/EP3938354A4/en active Pending
- 2020-03-13 SG SG11202109662Y patent/SG11202109662YA/en unknown
- 2020-03-13 AU AU2020241703A patent/AU2020241703B2/en active Active
- 2020-03-13 CA CA3133688A patent/CA3133688A1/en active Pending
- 2020-03-13 JP JP2021555445A patent/JP7474269B2/ja active Active
- 2020-03-13 CN CN202080034742.XA patent/CN113811528A/zh active Pending
- 2020-03-13 CR CR20210498A patent/CR20210498A/es unknown
- 2020-03-13 PH PH1/2021/552208A patent/PH12021552208A1/en unknown
-
2021
- 2021-09-13 IL IL286350A patent/IL286350A/en unknown
- 2021-09-14 US US17/475,144 patent/US11377451B2/en active Active
- 2021-09-15 CL CL2021002409A patent/CL2021002409A1/es unknown
- 2021-09-15 SA SA521430328A patent/SA521430328B1/ar unknown
- 2021-10-11 CO CONC2021/0013496A patent/CO2021013496A2/es unknown
-
2022
- 2022-06-29 US US17/853,573 patent/US20230115366A1/en not_active Abandoned
-
2024
- 2024-04-12 JP JP2024064400A patent/JP7789832B2/ja active Active
- 2024-06-12 US US18/741,322 patent/US20250145634A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526266A5 (https=) | ||
| CA2673451C (en) | Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | |
| JP6673920B2 (ja) | Ｐａｒｇ阻害化合物 | |
| JP5261575B2 (ja) | 化学化合物 | |
| JP7568641B2 (ja) | 治療的使用のためのキナーゼ阻害剤としての複素環式化合物 | |
| JP7274765B2 (ja) | フェニルトリアゾールｍｌｌ１－ｗｄｒ５タンパク質間相互作用阻害剤 | |
| ES2576497T3 (es) | Compuesto de piperidina novedoso o sal del mismo | |
| JP2020503299A5 (https=) | ||
| JP2016522246A5 (https=) | ||
| BRPI0813999A2 (pt) | ciclopentanos de pirimidil como inibidores de akt proteína cinase | |
| WO2017049462A1 (zh) | 一类新型的flt3激酶抑制剂及其用途 | |
| EP2702055A1 (en) | Pyrazolyl-pyrimidine derivatives as kinase inhibitors | |
| AU2016361834B2 (en) | 1,3,4-thiadiazole compounds and their use in treating cancer | |
| RU2009119181A (ru) | Гетероциклические соединения и их применение в качестве ингибиторов гликогенсинтаза-киназы-3 | |
| WO2022083657A1 (zh) | 取代苯并或吡啶并嘧啶胺类抑制剂及其制备方法和应用 | |
| JP2022550353A5 (https=) | ||
| JP2025509965A5 (https=) | ||
| CN107459521B (zh) | Flt3激酶的新型抑制剂及其用途 | |
| CN114195771A (zh) | 多激酶抑制剂及其用途 | |
| AU2019431153B2 (en) | New-type pan-RAF kinase inhibitor and use thereof | |
| CN105050602B (zh) | 作为pi3激酶抑制剂的吡啶化合物 | |
| JP2021533143A5 (https=) | ||
| JP6293770B2 (ja) | ヘッジホッグシグナル伝達経路阻害剤としての環状スルホンアミド含有誘導体 | |
| CN109942544B (zh) | 一类新型吲唑类衍生物激酶抑制剂 | |
| CN111138426B (zh) | 吲唑类激酶抑制剂及其用途 |